Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Omega-3 Partnership Between Fjordlaks and Borregaard
Fjordlaks and Borregaard have entered into a long-term strategic agreement for Omega-3 oils, under which Fjordlaks will deliver high quality crude fish oils which will be refined and marketed by Borregaard’s wholly owned subsidiary, Denomega Nutritional Oils.
- Omega-3 Partnership Between Fjordlaks and Borregaard
Fjordlaks and Borregaard have entered into a long-term strategic agreement for Omega-3 oils, under which Fjordlaks will deliver high quality crude fish oils which will be refined and marketed by Borregaard’s wholly owned subsidiary, Denomega Nutritional Oils.
- Omega-3 Partnership Between Fjordlaks and Borregaard
Fjordlaks and Borregaard have entered into a long-term strategic agreement for Omega-3 oils, under which Fjordlaks will deliver high quality crude fish oils which will be refined and marketed by Borregaard’s wholly owned subsidiary, Denomega Nutritional Oils.
- Omega-3 Partnership Between Fjordlaks and Borregaard
Fjordlaks and Borregaard have entered into a long-term strategic agreement for Omega-3 oils, under which Fjordlaks will deliver high quality crude fish oils which will be refined and marketed by Borregaard’s wholly owned subsidiary, Denomega Nutritional Oils.
- Omega-3 Partnership Between Fjordlaks and Borregaard
Fjordlaks and Borregaard have entered into a long-term strategic agreement for Omega-3 oils, under which Fjordlaks will deliver high quality crude fish oils which will be refined and marketed by Borregaard’s wholly owned subsidiary, Denomega Nutritional Oils.
- Omega-3 Partnership Between Fjordlaks and Borregaard
Fjordlaks and Borregaard have entered into a long-term strategic agreement for Omega-3 oils, under which Fjordlaks will deliver high quality crude fish oils which will be refined and marketed by Borregaard’s wholly owned subsidiary, Denomega Nutritional Oils.
- Omega-3 Partnership Between Fjordlaks and Borregaard
Fjordlaks and Borregaard have entered into a long-term strategic agreement for Omega-3 oils, under which Fjordlaks will deliver high quality crude fish oils which will be refined and marketed by Borregaard’s wholly owned subsidiary, Denomega Nutritional Oils.
- Embria Health Sciences' EpiCor Achieves Self-Determined GRAS Status
Company has successfully achieved self-determined Generally Regarded as Safe (GRAS) status with panelists including Theodore M. Farber, Ph.D., DABT (Chair) – Consulting Toxicologist, Norbert Page, Ph.D., DABT – Adjunct Professor of Toxicology at University of Maryland, Joseph Borzelleca, Ph.D., DABT – Professor Emeritus, Pharmacology and Toxicology at Medical College of Virginia and Virginia Commonwealth University and current editor for international journal, Food and Chemical Toxicology.
- Embria Health Sciences' EpiCor Achieves Self-Determined GRAS Status
Company has successfully achieved self-determined Generally Regarded as Safe (GRAS) status with panelists including Theodore M. Farber, Ph.D., DABT (Chair) – Consulting Toxicologist, Norbert Page, Ph.D., DABT – Adjunct Professor of Toxicology at University of Maryland, Joseph Borzelleca, Ph.D., DABT – Professor Emeritus, Pharmacology and Toxicology at Medical College of Virginia and Virginia Commonwealth University and current editor for international journal, Food and Chemical Toxicology.
- Embria Health Sciences' EpiCor Achieves Self-Determined GRAS Status
Company has successfully achieved self-determined Generally Regarded as Safe (GRAS) status with panelists including Theodore M. Farber, Ph.D., DABT (Chair) – Consulting Toxicologist, Norbert Page, Ph.D., DABT – Adjunct Professor of Toxicology at University of Maryland, Joseph Borzelleca, Ph.D., DABT – Professor Emeritus, Pharmacology and Toxicology at Medical College of Virginia and Virginia Commonwealth University and current editor for international journal, Food and Chemical Toxicology.
- Embria Health Sciences' EpiCor Achieves Self-Determined GRAS Status
Company has successfully achieved self-determined Generally Regarded as Safe (GRAS) status with panelists including Theodore M. Farber, Ph.D., DABT (Chair) – Consulting Toxicologist, Norbert Page, Ph.D., DABT – Adjunct Professor of Toxicology at University of Maryland, Joseph Borzelleca, Ph.D., DABT – Professor Emeritus, Pharmacology and Toxicology at Medical College of Virginia and Virginia Commonwealth University and current editor for international journal, Food and Chemical Toxicology.
- Embria Health Sciences' EpiCor Achieves Self-Determined GRAS Status
Company has successfully achieved self-determined Generally Regarded as Safe (GRAS) status with panelists including Theodore M. Farber, Ph.D., DABT (Chair) – Consulting Toxicologist, Norbert Page, Ph.D., DABT – Adjunct Professor of Toxicology at University of Maryland, Joseph Borzelleca, Ph.D., DABT – Professor Emeritus, Pharmacology and Toxicology at Medical College of Virginia and Virginia Commonwealth University and current editor for international journal, Food and Chemical Toxicology.
- Embria Health Sciences' EpiCor Achieves Self-Determined GRAS Status
Company has successfully achieved self-determined Generally Regarded as Safe (GRAS) status with panelists including Theodore M. Farber, Ph.D., DABT (Chair) – Consulting Toxicologist, Norbert Page, Ph.D., DABT – Adjunct Professor of Toxicology at University of Maryland, Joseph Borzelleca, Ph.D., DABT – Professor Emeritus, Pharmacology and Toxicology at Medical College of Virginia and Virginia Commonwealth University and current editor for international journal, Food and Chemical Toxicology.
- Embria Health Sciences' EpiCor Achieves Self-Determined GRAS Status
Company has successfully achieved self-determined Generally Regarded as Safe (GRAS) status with panelists including Theodore M. Farber, Ph.D., DABT (Chair) – Consulting Toxicologist, Norbert Page, Ph.D., DABT – Adjunct Professor of Toxicology at University of Maryland, Joseph Borzelleca, Ph.D., DABT – Professor Emeritus, Pharmacology and Toxicology at Medical College of Virginia and Virginia Commonwealth University and current editor for international journal, Food and Chemical Toxicology.
- Embria Health Sciences' EpiCor Achieves Self-Determined GRAS Status
Company has successfully achieved self-determined Generally Regarded as Safe (GRAS) status with panelists including Theodore M. Farber, Ph.D., DABT (Chair) – Consulting Toxicologist, Norbert Page, Ph.D., DABT – Adjunct Professor of Toxicology at University of Maryland, Joseph Borzelleca, Ph.D., DABT – Professor Emeritus, Pharmacology and Toxicology at Medical College of Virginia and Virginia Commonwealth University and current editor for international journal, Food and Chemical Toxicology.
- Next Pharmaceuticals Announces New Delivery Form for Relora®
Company announces that a microencapsulated concentrate version of the ingredient Relora® is now available.
- Next Pharmaceuticals Announces New Delivery Form for Relora®
Company announces that a microencapsulated concentrate version of the ingredient Relora® is now available.
- Next Pharmaceuticals Announces New Delivery Form for Relora®
Company announces that a microencapsulated concentrate version of the ingredient Relora® is now available.
- Next Pharmaceuticals Announces New Delivery Form for Relora®
Company announces that a microencapsulated concentrate version of the ingredient Relora® is now available.
- Next Pharmaceuticals Announces New Delivery Form for Relora®
Company announces that a microencapsulated concentrate version of the ingredient Relora® is now available.
- Next Pharmaceuticals Announces New Delivery Form for Relora®
Company announces that a microencapsulated concentrate version of the ingredient Relora® is now available.
- EuroPharma Appointed Exclusive US Distributor of New Omega-3 With Biological Absorption Level Higher than Other Fish Oils
EuroPharma has entered into an exclusive North American distribution agreement for Vectomega®, a natural marine complex made up of five different phospholipids, DHA and EPA, along with proteins and amino acids as they occur in nature.
- EuroPharma Appointed Exclusive US Distributor of New Omega-3 With Biological Absorption Level Higher than Other Fish Oils
EuroPharma has entered into an exclusive North American distribution agreement for Vectomega®, a natural marine complex made up of five different phospholipids, DHA and EPA, along with proteins and amino acids as they occur in nature.
- EuroPharma Appointed Exclusive US Distributor of New Omega-3 With Biological Absorption Level Higher than Other Fish Oils
EuroPharma has entered into an exclusive North American distribution agreement for Vectomega®, a natural marine complex made up of five different phospholipids, DHA and EPA, along with proteins and amino acids as they occur in nature.
- EuroPharma Appointed Exclusive US Distributor of New Omega-3 With Biological Absorption Level Higher than Other Fish Oils
EuroPharma has entered into an exclusive North American distribution agreement for Vectomega®, a natural marine complex made up of five different phospholipids, DHA and EPA, along with proteins and amino acids as they occur in nature.
- EuroPharma Appointed Exclusive US Distributor of New Omega-3 With Biological Absorption Level Higher than Other Fish Oils
EuroPharma has entered into an exclusive North American distribution agreement for Vectomega®, a natural marine complex made up of five different phospholipids, DHA and EPA, along with proteins and amino acids as they occur in nature.
- EuroPharma Appointed Exclusive US Distributor of New Omega-3 With Biological Absorption Level Higher than Other Fish Oils
EuroPharma has entered into an exclusive North American distribution agreement for Vectomega®, a natural marine complex made up of five different phospholipids, DHA and EPA, along with proteins and amino acids as they occur in nature.
- EuroPharma Appointed Exclusive US Distributor of New Omega-3 With Biological Absorption Level Higher than Other Fish Oils
EuroPharma has entered into an exclusive North American distribution agreement for Vectomega®, a natural marine complex made up of five different phospholipids, DHA and EPA, along with proteins and amino acids as they occur in nature.
- Zsweet(TM), 100% All Natural, Zero Calorie Sweetener, Shows No Impact on Blood Sugar
Company has announced completion of a clinical study to determine the ultra-low glycemic response in humans on Zsweet(TM), patent-pending sweetener. Study indicated that consuming 15 grams (3 tsp.) of Zsweet(TM), on average, did not raise or lower blood glucose levels in healthy individuals
- Zsweet(TM), 100% All Natural, Zero Calorie Sweetener, Shows No Impact on Blood Sugar
Company has announced completion of a clinical study to determine the ultra-low glycemic response in humans on Zsweet(TM), patent-pending sweetener. Study indicated that consuming 15 grams (3 tsp.) of Zsweet(TM), on average, did not raise or lower blood glucose levels in healthy individuals
- Zsweet(TM), 100% All Natural, Zero Calorie Sweetener, Shows No Impact on Blood Sugar
Company has announced completion of a clinical study to determine the ultra-low glycemic response in humans on Zsweet(TM), patent-pending sweetener. Study indicated that consuming 15 grams (3 tsp.) of Zsweet(TM), on average, did not raise or lower blood glucose levels in healthy individuals
- Zsweet(TM), 100% All Natural, Zero Calorie Sweetener, Shows No Impact on Blood Sugar
Company has announced completion of a clinical study to determine the ultra-low glycemic response in humans on Zsweet(TM), patent-pending sweetener. Study indicated that consuming 15 grams (3 tsp.) of Zsweet(TM), on average, did not raise or lower blood glucose levels in healthy individuals
- Zsweet(TM), 100% All Natural, Zero Calorie Sweetener, Shows No Impact on Blood Sugar
Company has announced completion of a clinical study to determine the ultra-low glycemic response in humans on Zsweet(TM), patent-pending sweetener. Study indicated that consuming 15 grams (3 tsp.) of Zsweet(TM), on average, did not raise or lower blood glucose levels in healthy individuals
- Zsweet(TM), 100% All Natural, Zero Calorie Sweetener, Shows No Impact on Blood Sugar
Company has announced completion of a clinical study to determine the ultra-low glycemic response in humans on Zsweet(TM), patent-pending sweetener. Study indicated that consuming 15 grams (3 tsp.) of Zsweet(TM), on average, did not raise or lower blood glucose levels in healthy individuals
- Zsweet(TM), 100% All Natural, Zero Calorie Sweetener, Shows No Impact on Blood Sugar
Company has announced completion of a clinical study to determine the ultra-low glycemic response in humans on Zsweet(TM), patent-pending sweetener. Study indicated that consuming 15 grams (3 tsp.) of Zsweet(TM), on average, did not raise or lower blood glucose levels in healthy individuals
- Effective, Safe, Doctor-Recommended DiosVein(TM) from Europe Addresses Vein Conditions
Berg Imports offers DiosVein(TM), bioflavanoid-rich and derived from Sweet Orange, made from the supplement diosmin, targeted at promoting healthy circulation.
- Effective, Safe, Doctor-Recommended DiosVein(TM) from Europe Addresses Vein Conditions
Berg Imports offers DiosVein(TM), bioflavanoid-rich and derived from Sweet Orange, made from the supplement diosmin, targeted at promoting healthy circulation.
- Effective, Safe, Doctor-Recommended DiosVein(TM) from Europe Addresses Vein Conditions
Berg Imports offers DiosVein(TM), bioflavanoid-rich and derived from Sweet Orange, made from the supplement diosmin, targeted at promoting healthy circulation.
- Effective, Safe, Doctor-Recommended DiosVein(TM) from Europe Addresses Vein Conditions
Berg Imports offers DiosVein(TM), bioflavanoid-rich and derived from Sweet Orange, made from the supplement diosmin, targeted at promoting healthy circulation.
- Effective, Safe, Doctor-Recommended DiosVein(TM) from Europe Addresses Vein Conditions
Berg Imports offers DiosVein(TM), bioflavanoid-rich and derived from Sweet Orange, made from the supplement diosmin, targeted at promoting healthy circulation.
- 7-Keto® from Humanetics is Part of Fat-burning Matrix Technology Behind Anadrox™ From MHP
MHP (Maximum Human Performance) recently introduced Anadrox(TM), a combination muscle growth/fat burning product which contains 7-Keto®, a branded ingredient from Humanetics Corporation
- 7-Keto® from Humanetics is Part of Fat-burning Matrix Technology Behind Anadrox™ From MHP
MHP (Maximum Human Performance) recently introduced Anadrox(TM), a combination muscle growth/fat burning product which contains 7-Keto®, a branded ingredient from Humanetics Corporation
- 7-Keto® from Humanetics is Part of Fat-burning Matrix Technology Behind Anadrox™ From MHP
MHP (Maximum Human Performance) recently introduced Anadrox(TM), a combination muscle growth/fat burning product which contains 7-Keto®, a branded ingredient from Humanetics Corporation
- 7-Keto® from Humanetics is Part of Fat-burning Matrix Technology Behind Anadrox™ From MHP
MHP (Maximum Human Performance) recently introduced Anadrox(TM), a combination muscle growth/fat burning product which contains 7-Keto®, a branded ingredient from Humanetics Corporation
- 7-Keto® from Humanetics is Part of Fat-burning Matrix Technology Behind Anadrox™ From MHP
MHP (Maximum Human Performance) recently introduced Anadrox(TM), a combination muscle growth/fat burning product which contains 7-Keto®, a branded ingredient from Humanetics Corporation
- 7-Keto® from Humanetics is Part of Fat-burning Matrix Technology Behind Anadrox™ From MHP
MHP (Maximum Human Performance) recently introduced Anadrox(TM), a combination muscle growth/fat burning product which contains 7-Keto®, a branded ingredient from Humanetics Corporation
- China’s First Yogurt Drink Launched With EPA And DHA From Fish Oil
Company announces the launch of China’s first drinkable yogurt, OMU brand drinkable yogurt, enriched with MEG-3® brand Omega-3 EPA/DHA made from fish oil.
- China’s First Yogurt Drink Launched With EPA And DHA From Fish Oil
Company announces the launch of China’s first drinkable yogurt, OMU brand drinkable yogurt, enriched with MEG-3® brand Omega-3 EPA/DHA made from fish oil.
- China’s First Yogurt Drink Launched With EPA And DHA From Fish Oil
Company announces the launch of China’s first drinkable yogurt, OMU brand drinkable yogurt, enriched with MEG-3® brand Omega-3 EPA/DHA made from fish oil.
- China’s First Yogurt Drink Launched With EPA And DHA From Fish Oil
Company announces the launch of China’s first drinkable yogurt, OMU brand drinkable yogurt, enriched with MEG-3® brand Omega-3 EPA/DHA made from fish oil.
- China’s First Yogurt Drink Launched With EPA And DHA From Fish Oil
Company announces the launch of China’s first drinkable yogurt, OMU brand drinkable yogurt, enriched with MEG-3® brand Omega-3 EPA/DHA made from fish oil.
- P.L. Thomas and Polifenoles Naturales, S.A. Announce Strategic Alliance
Polifenoles Naturales, S.L. (POLINAT) European Research of Natural Products Center and producer of standardized fruit and botanical extracts and P. L. Thomas (PLT) have announced a strategic alliance to develop and market unique ingredients for the nutraceuticals, food and beverage markets.
- P.L. Thomas and Polifenoles Naturales, S.A. Announce Strategic Alliance
Polifenoles Naturales, S.L. (POLINAT) European Research of Natural Products Center and producer of standardized fruit and botanical extracts and P. L. Thomas (PLT) have announced a strategic alliance to develop and market unique ingredients for the nutraceuticals, food and beverage markets.
- P.L. Thomas and Polifenoles Naturales, S.A. Announce Strategic Alliance
Polifenoles Naturales, S.L. (POLINAT) European Research of Natural Products Center and producer of standardized fruit and botanical extracts and P. L. Thomas (PLT) have announced a strategic alliance to develop and market unique ingredients for the nutraceuticals, food and beverage markets.
- P.L. Thomas and Polifenoles Naturales, S.A. Announce Strategic Alliance
Polifenoles Naturales, S.L. (POLINAT) European Research of Natural Products Center and producer of standardized fruit and botanical extracts and P. L. Thomas (PLT) have announced a strategic alliance to develop and market unique ingredients for the nutraceuticals, food and beverage markets.
- P.L. Thomas and Polifenoles Naturales, S.A. Announce Strategic Alliance
Polifenoles Naturales, S.L. (POLINAT) European Research of Natural Products Center and producer of standardized fruit and botanical extracts and P. L. Thomas (PLT) have announced a strategic alliance to develop and market unique ingredients for the nutraceuticals, food and beverage markets.
- P.L. Thomas and Polifenoles Naturales, S.A. Announce Strategic Alliance
Polifenoles Naturales, S.L. (POLINAT) European Research of Natural Products Center and producer of standardized fruit and botanical extracts and P. L. Thomas (PLT) have announced a strategic alliance to develop and market unique ingredients for the nutraceuticals, food and beverage markets.
- Triarco’s Aminogen® Increases Plasma Amino Acid Levels Over 100%
Study comprising of 41 males was designed to find out whether the presence of Triarco’s patented ingredient Aminogen makes a difference in the breakdown, absorption and utilization of whey protein.
- Triarco’s Aminogen® Increases Plasma Amino Acid Levels Over 100%
Study comprising of 41 males was designed to find out whether the presence of Triarco’s patented ingredient Aminogen makes a difference in the breakdown, absorption and utilization of whey protein.
- Triarco’s Aminogen® Increases Plasma Amino Acid Levels Over 100%
Study comprising of 41 males was designed to find out whether the presence of Triarco’s patented ingredient Aminogen makes a difference in the breakdown, absorption and utilization of whey protein.
- Triarco’s Aminogen® Increases Plasma Amino Acid Levels Over 100%
Study comprising of 41 males was designed to find out whether the presence of Triarco’s patented ingredient Aminogen makes a difference in the breakdown, absorption and utilization of whey protein.
- First Endurance Launches Multi-V Containing Triarco’s Carbogen®
introducing Multi-V, formulation contains clinically effective doses of Triarco’s patented ingredient, Carbogen.
- First Endurance Launches Multi-V Containing Triarco’s Carbogen®
introducing Multi-V, formulation contains clinically effective doses of Triarco’s patented ingredient, Carbogen.
- First Endurance Launches Multi-V Containing Triarco’s Carbogen®
introducing Multi-V, formulation contains clinically effective doses of Triarco’s patented ingredient, Carbogen.
- First Endurance Launches Multi-V Containing Triarco’s Carbogen®
introducing Multi-V, formulation contains clinically effective doses of Triarco’s patented ingredient, Carbogen.
- First Endurance Launches Multi-V Containing Triarco’s Carbogen®
introducing Multi-V, formulation contains clinically effective doses of Triarco’s patented ingredient, Carbogen.
- Serotain® Scores Almost 70% on SSRI Bioassay
- Serotain® Scores Almost 70% on SSRI Bioassay
- Serotain® Scores Almost 70% on SSRI Bioassay
- Serotain® Scores Almost 70% on SSRI Bioassay
- Tate & Lyle Interim Results Announcement 2009
Tate & Lyle has announced their 2009 Interim results, reporting the Group's performance, before the impact of exchange translation, remains on track to meet our expectations for the full year.
- NPI Daily - Top of The News for Nov. 6, 2009 - National Organic Standards Board Votes to Crack Down on Organic Personal Care Cheaters
Nature's Sunshine Products Reports FY09 Q3 Operating Results; SunOpta Announces FY09 Q3 Results; Tate & Lyle Interim Results Announcement 2009; NOW Foods Receives the 2009 Illinois Governor's Sustainability Award; Transport-C Supports Vitamin Angels at SSW; Cantox at Supplyside West; New Support Showing Immunoglobulin Supplementation Enhances Immune System; FDA Warning: Over-the-Counter Sex Enhancement Drug May Cause 'Dangerously' Low Blood Pressure; EPAX AS Achieves 'Friend of the Sea' Certification; National Organic Standards Board Votes to Crack Down on Organic Personal Care Cheaters; Fast-C™ At SupplySide West: US Clinical Trials Data Available In Booth ; Nutty Flavor & Healthy Boost of Omega-3 Make Hemp Seed an Ideal Ingredient; DSM's tensVida® Recognized for Innovative Development; Nutrition 21 Announces Addition of Innovative New Probiotic + Omega-3 Fish Oil Combination Product; Glanbia Nutritionals Offers More Than Ingredients for Nutritional Beverages; Whole Foods Market(R) Offers Natural Solutions to Help Build Up Body Defenses With Immune System Support; Doug Reyes Joins Embria as Regional Sales Manager; Michael F. Hines Joins Board of General Nutrition Centers, Inc.; Dr. Arnold Hirsch Celebrates 50th Anniversary with the American Chemical Society
- NPI Daily - Top of The News for Nov. 6, 2009 - National Organic Standards Board Votes to Crack Down on Organic Personal Care Cheaters
Nature's Sunshine Products Reports FY09 Q3 Operating Results; SunOpta Announces FY09 Q3 Results; Tate & Lyle Interim Results Announcement 2009; NOW Foods Receives the 2009 Illinois Governor's Sustainability Award; Transport-C Supports Vitamin Angels at SSW; Cantox at Supplyside West; New Support Showing Immunoglobulin Supplementation Enhances Immune System; FDA Warning: Over-the-Counter Sex Enhancement Drug May Cause 'Dangerously' Low Blood Pressure; EPAX AS Achieves 'Friend of the Sea' Certification; National Organic Standards Board Votes to Crack Down on Organic Personal Care Cheaters; Fast-C™ At SupplySide West: US Clinical Trials Data Available In Booth ; Nutty Flavor & Healthy Boost of Omega-3 Make Hemp Seed an Ideal Ingredient; DSM's tensVida® Recognized for Innovative Development; Nutrition 21 Announces Addition of Innovative New Probiotic + Omega-3 Fish Oil Combination Product; Glanbia Nutritionals Offers More Than Ingredients for Nutritional Beverages; Whole Foods Market(R) Offers Natural Solutions to Help Build Up Body Defenses With Immune System Support; Doug Reyes Joins Embria as Regional Sales Manager; Michael F. Hines Joins Board of General Nutrition Centers, Inc.; Dr. Arnold Hirsch Celebrates 50th Anniversary with the American Chemical Society
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Carlson Laboratories Receives Better Nutrition Best of Supplements Awards for 2009
Carlson Laboratories has received awards for three of its products in this year's Best of Supplements Awards presented by Better Nutrition Magazine.
- Carlson Laboratories Receives Better Nutrition Best of Supplements Awards for 2009
Carlson Laboratories has received awards for three of its products in this year's Best of Supplements Awards presented by Better Nutrition Magazine.
- Carlson Laboratories Receives Better Nutrition Best of Supplements Awards for 2009
Carlson Laboratories has received awards for three of its products in this year's Best of Supplements Awards presented by Better Nutrition Magazine.
- Carlson Laboratories Receives Better Nutrition Best of Supplements Awards for 2009
Carlson Laboratories has received awards for three of its products in this year's Best of Supplements Awards presented by Better Nutrition Magazine.
- Carlson Laboratories Receives Better Nutrition Best of Supplements Awards for 2009
Carlson Laboratories has received awards for three of its products in this year's Best of Supplements Awards presented by Better Nutrition Magazine.
- Sharp-GPC™ 45F by Enzymotec
Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline.
- Sharp-GPC™ 45F by Enzymotec
Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline.
- Sharp-GPC™ 45F by Enzymotec
Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline.
- Sharp-GPC™ 45F by Enzymotec
Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline.
- Sharp-GPC™ 45F by Enzymotec
Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline.
- Sharp-GPC™ 45F by Enzymotec
Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline.
- Natural Products Foundation Representatives Meet with Federal Regulators on Truth in Advertising Campaign
The Natural Products Foundation recently met with officials from both U.S. Food and Drug Administration and Federal Trade Commission to turn over the names of 10 companies that have continued to make drug or disease claims in their advertising and other promotional materials.
- Natural Products Foundation Representatives Meet with Federal Regulators on Truth in Advertising Campaign
The Natural Products Foundation recently met with officials from both U.S. Food and Drug Administration and Federal Trade Commission to turn over the names of 10 companies that have continued to make drug or disease claims in their advertising and other promotional materials.
- Natural Products Foundation Representatives Meet with Federal Regulators on Truth in Advertising Campaign
The Natural Products Foundation recently met with officials from both U.S. Food and Drug Administration and Federal Trade Commission to turn over the names of 10 companies that have continued to make drug or disease claims in their advertising and other promotional materials.
- Natural Products Foundation Representatives Meet with Federal Regulators on Truth in Advertising Campaign
The Natural Products Foundation recently met with officials from both U.S. Food and Drug Administration and Federal Trade Commission to turn over the names of 10 companies that have continued to make drug or disease claims in their advertising and other promotional materials.
- Natural Products Foundation Representatives Meet with Federal Regulators on Truth in Advertising Campaign
The Natural Products Foundation recently met with officials from both U.S. Food and Drug Administration and Federal Trade Commission to turn over the names of 10 companies that have continued to make drug or disease claims in their advertising and other promotional materials.
- Taming Fear of the H1N1 Flu Vaccine
- Taming Fear of the H1N1 Flu Vaccine
- Natural Cold and Flu Remedies: Do They Help?
- Natural Cold and Flu Remedies: Do They Help?
- Exercise as Pain Therapy
- Exercise as Pain Therapy
|
KEARNY, NJ, JUNE 1, 2006—Pharmachem Laboratories, Inc., today announced that its branded white bean extract, Phase 2 Starch Neutralizer®, has been designated “generally recognized as safe,” (GRAS). Pharmachem received the notification from research firm, Cantox U.S., Inc., who organized the expert panel and scientific review.
“The panel unanimously agrees that, anticipating final publication of the 28-day rat safety study, Phase 2 is GRAS for use in supplements and food products (that are not restricted by standard of identity) yielding consumption of up to 6.0 grams Phase 2 per day,” said David H. Bechtel, Ph.D., DABT, Managing Director and Senior Scientific Consultant, Cantox U.S., Inc. According to an expert opinion statement, the “experts unanimously agreed that the long-time presence of Phaseolus vulgaris in the human diet and its digestion by normal physiological pathways is supporting evidence of the safety of Phase 2. Also supportive is its current widespread use in dietary supplements, with no known adverse events.” To supplement this evidence, “Pharmachem conducted a series of studies, and was confident in the safety of its ingredient,” said Mitch Skop, Director of new product development. “While all our studies concluded Phase 2 was safe, it is gratifying to receive the GRAS designation for the assurance of our customers, particularly as we move into many new, exciting food applications.” The expert opinion statement said, “The results of pivotal nonclinical safety studies indicate that Phase 2 and dietary supplements containing Phase 2 is of low toxicological concern. Supportive evidence of safety was also presented in clinical studies, conducted in both the U.S. and Europe, designed to primarily examine the effects of Phase 2 or dietary supplements containing Phase 2 on glucose response and body weight loss. However, at least two studies included tests for hematology, clinical chemistry, and/or unrinalysis. During these studies, Phase 2 was administered to healthy subjects with meals for periods from 30 days to 24 weeks. No effects of toxicological concern were observed.” “GRAS status will accelerate the launch of Phase 2 into the food and beverage industries as our StarchLite® line of ingredients rolls out worldwide,” added Skop.
Pharmachem Laboratories, Kearny, NJ, is the supplier of Phase 2 starch neutralizer. The company develops, supplies and manufactures a variety of high-quality, efficacious food ingredients under the strictest quality control. For more information, log-on to www.phase2info.com; or call 1-800-526-0609.
# # # |